Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

Clinical and Vaccine Immunology Minireviews

View Other ASM Journals Minireviews: Minireview Collection

From the Current Issue: March 2010; volume 17, issue 3 [Table of Contents]

There are no Minireviews articles in the current issue.

From Past Issues:

Vaccines: the Fourth Century

Stanley A. Plotkin
Clin. Vaccine Immunol. 2009. 16:1709-1719. [Abstract] [HTML] [PDF]

Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2

Dong Liu, Jian-Ying Zhu, and Zhong-Xiang Niu
Clin. Vaccine Immunol. 2008. 15:901-910. [HTML] [PDF]

Lyme Arthritis: Current Concepts and a Change in Paradigm

Dean T. Nardelli, Steven M. Callister, and Ronald F. Schell
Clin. Vaccine Immunol. 2008. 15:21-34. [HTML] [PDF]

Frequency, Causes, and New Challenges of Indeterminate Results in Western Blot Confirmatory Testing for Antibodies to Human Immunodeficiency Virus

Ming Guan
Clin. Vaccine Immunol. 2007. 14:649-659. [HTML] [PDF]

Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria

C. Maldonado Galdeano, A. de Moreno de LeBlanc, G. Vinderola, M. E. Bibas Bonet, and G. Perdigon
Clin. Vaccine Immunol. 2007. 14:485-492. [HTML] [PDF]

Vaccines: All Things Considered

Ken S. Rosenthal and Daniel H. Zimmerman
Clin. Vaccine Immunol. 2006. 13:821-829. [HTML] [PDF]

Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis

Diana Finzi, Susan F. Plaeger, and Carl W. Dieffenbach
Clin. Vaccine Immunol. 2006. 13:715-721. [HTML] [PDF]

Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised Individuals

Sallie R. Permar, Diane E. Griffin, and Norman L. Letvin
Clin. Vaccine Immunol. 2006. 13:437-443. [HTML] [PDF]

Laboratory Diagnostic Systems for Ebola and Marburg Hemorrhagic Fevers Developed with Recombinant Proteins

Masayuki Saijo, Masahiro Niikura, Tetsuro Ikegami, Ichiro Kurane, Takeshi Kurata, and Shigeru Morikawa
Clin. Vaccine Immunol. 2006. 13:444-451. [HTML] [PDF]

Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines

Sandra Romero-Steiner, Carl E. Frasch, George Carlone, Roland A. Fleck, David Goldblatt, and Moon H. Nahm
Clin. Vaccine Immunol. 2006. 13:165-169. [HTML] [PDF]

Whipple's Disease: a Macrophage Disease

Benoit Desnues, Melanie Ihrig, Didier Raoult, and Jean-Louis Mege
Clin. Vaccine Immunol. 2006. 13:170-178. [HTML] [PDF]

The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench

Melanie C. Bacon, Viktor von Wyl, Christine Alden, Gerald Sharp, Esther Robison, Nancy Hessol, Stephen Gange, Yvonne Barranday, Susan Holman, Kathleen Weber, and Mary A. Young
Clin. Vaccine Immunol. 2005. 12:1013-1019. [HTML] [PDF]

Phagocytic Activity in Human Immunodeficiency Virus Type 1 Infection

Agostino Pugliese, Valerio Vidotto, Tiziana Beltramo, and Donato Torre
Clin. Vaccine Immunol. 2005. 12:889-895. [HTML] [PDF]

Use of HL-60 Cell Line To Measure Opsonic Capacity of Pneumococcal Antibodies

R. A. Fleck, S. Romero-Steiner, and M. H. Nahm
Clin. Vaccine Immunol. 2005. 12:19-27. [HTML] [PDF]

Current Methods for Detecting Antibodies against Erythropoietin and Other Recombinant Proteins

Robin Thorpe and Steven J Swanson
Clin. Vaccine Immunol. 2005. 12:28-39. [HTML] [PDF]

Antigenic Diversity and Immune Evasion by Malaria Parasites

Marcelo U. Ferreira, Monica da Silva Nunes, and Gerhard Wunderlich
Clin. Vaccine Immunol. 2004. 11:987-995. [HTML] [PDF]

Expanding Role of Circulating Adhesion Molecules in Assessing Prognosis and Treatment Response in Human Immunodeficiency Virus Infection

Nikolaos V. Sipsas and Petros P. Sfikakis
Clin. Vaccine Immunol. 2004. 11:996-1001. [HTML] [PDF]

Impact of Immune Plasticity on Development of Cellular Memory Responses to Human Immunodeficiency Virus Type 1

Michael A. Kolber
Clin. Vaccine Immunol. 2004. 11:1002-1007. [HTML] [PDF]

Targeting CD40L: a Promising Therapeutic Approach

Dimitris Daoussis, Andrew P. Andonopoulos, and Stamatis-Nick C. Liossis
Clin. Vaccine Immunol. 2004. 11:635-641. [HTML] [PDF]

Current Advances in Dengue Diagnosis

Pei-Yun Shu and Jyh-Hsiung Huang
Clin. Vaccine Immunol. 2004. 11:642-650. [HTML] [PDF]

Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism?

L. Aurelian
Clin. Vaccine Immunol. 2004. 11:437-445. [Abstract] [HTML] [PDF]

Multiple Effects of the M184V Resistance Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1

Dan Turner, Bluma Brenner, and Mark A. Wainberg
Clin. Vaccine Immunol. 2003. 10:979-981. [HTML] [PDF]

Modern Complement Analysis

Michael Kirschfink and Tom E. Mollnes
Clin. Vaccine Immunol. 2003. 10:982-989. [HTML] [PDF]

Clinical Application of Beryllium Lymphocyte Proliferation Testing

Barbara P. Barna, Daniel A. Culver, Belinda Yen-Lieberman, Raed A. Dweik, and Mary Jane Thomassen
Clin. Vaccine Immunol. 2003. 10:990-994. [HTML] [PDF]

Laboratory Diagnosis of Heparin-Induced Thrombocytopenia and Monitoring of Alternative Anticoagulants

Albrecht Leo and Susanne Winteroll
Clin. Vaccine Immunol. 2003. 10:731-740. [HTML] [PDF]

Lipoprotein Autoantibodies: Measurement and Significance

Gabriel Virella and Maria F. Lopes-Virella
Clin. Vaccine Immunol. 2003. 10:499-505. [HTML] [PDF]

Immunological Methods for Detection and Identification of Infectious Disease and Biological Warfare Agents

Anne Harwood Peruski and Leonard F. Peruski Jr.
Clin. Vaccine Immunol. 2003. 10:506-513. [HTML] [PDF]

Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides

Catherine M. Wernette, Carl E. Frasch, Dace Madore, George Carlone, David Goldblatt, Brian Plikaytis, William Benjamin, Sally A. Quataert, Steve Hildreth, Daniel J. Sikkema, Helena Kayhty, Ingileif Jonsdottir, and Moon H. Nahm
Clin. Vaccine Immunol. 2003. 10:514-519. [HTML] [PDF]

Herpesvirus Infections in Organ Transplant Recipients

Frank J. Jenkins, David T. Rowe, and Charles R. Rinaldo Jr.
Clin. Vaccine Immunol. 2003. 10:1-7. [HTML] [PDF]

Cytokines in the Pathogenesis of and Protection against Malaria

Inigo Angulo and Manuel Fresno
Clin. Vaccine Immunol. 2002. 9:1145-1152. [HTML] [PDF]

Jaks, STATs, Cytokines, and Sepsis

Melanie J. Scott, Christopher J. Godshall, and William G. Cheadle
Clin. Vaccine Immunol. 2002. 9:1153-1159. [HTML] [PDF]

Biological and Clinical Significance of Lipids as Modulators of Immune System Functions

Manuel A. de Pablo, Maria A. Puertollano, and Gerardo Alvarez de Cienfuegos
Clin. Vaccine Immunol. 2002. 9:945-950. [HTML] [PDF]

Laboratory Diagnosis of Visceral Leishmaniasis

Shyam Sundar and M. Rai
Clin. Vaccine Immunol. 2002. 9:951-958. [HTML] [PDF]

Impaired Regulation of HLA-DR Expression in Human Immunodeficiency Virus-Infected Monocytes

Ling Shao and Kirk Sperber
Clin. Vaccine Immunol. 2002. 9:739-746. [HTML] [PDF]

Evidence for the Presence of Immune Dysfunction in Chronic Fatigue Syndrome

Benjamin H. Natelson, Mohammad H. Haghighi, and Nicholas M. Ponzio
Clin. Vaccine Immunol. 2002. 9:747-752. [HTML] [PDF]

Evaluation of Events Occurring at Mucosal Surfaces: Techniques Used To Collect and Analyze Mucosal Secretions and Cells

Bruno Guy
Clin. Vaccine Immunol. 2002. 9:753-762. [HTML] [PDF]

PCR in Diagnosis of Infection: Detection of Bacteria in Cerebrospinal Fluids

Yoshimasa Yamamoto
Clin. Vaccine Immunol. 2002. 9:508-514. [HTML] [PDF]

In Vitro and Animal Models of Human Immunodeficiency Virus Infection of the Central Nervous System

Chadd E. Nesbit and Stanley A. Schwartz
Clin. Vaccine Immunol. 2002. 9:515-524. [HTML] [PDF]

Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis

Claudia Stollberger and Josef Finsterer
Clin. Vaccine Immunol. 2002. 9:207-215. [HTML] [PDF]

Development and Use of Multimeric Major Histocompatibility Complex Molecules

Tim F. Greten and Jonathan P. Schneck
Clin. Vaccine Immunol. 2002. 9:216-220. [HTML] [PDF]

Autoantibodies to Extractable Nuclear Antigens: Making Detection and Interpretation More Meaningful

Tri Giang Phan, Richard C. W. Wong, and Stephen Adelstein
Clin. Vaccine Immunol. 2002. 9:1-7. [HTML] [PDF]

Natural History of Bartonella Infections (an Exception to Koch’s Postulate)

V. Jacomo, P. J. Kelly, and D. Raoult
Clin. Vaccine Immunol. 2002. 9:8-18. [HTML] [PDF]

Retinopathies Associated with Antiretinal Antibodies

John J. Hooks, Mark O. M. Tso, and Barbara Detrick
Clin. Vaccine Immunol. 2001. 8:853-858. [HTML] [PDF]

Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases

Val G. Hemming
Clin. Vaccine Immunol. 2001. 8:859-863. [HTML] [PDF]

Immunological Effects of Interleukin-2 Therapy in Human Immunodeficiency Virus-Positive Subjects

Paolo De Paoli
Clin. Vaccine Immunol. 2001. 8:671-677. [HTML] [PDF]

Celiac Disease-Associated Autoimmune Endocrinopathies

Vijay Kumar, Manoj Rajadhyaksha, and Jacobo Wortsman
Clin. Vaccine Immunol. 2001. 8:678-685. [Abstract] [HTML] [PDF]

Cell-Mediated Immune Response to Human Papillomavirus Infection

Mark Scott, Mayumi Nakagawa, and Anna-Barbara Moscicki
Clin. Vaccine Immunol. 2001. 8:209-220. [HTML] [PDF]

Whipple's Disease

Florence Fenollar and Didier Raoult
Clin. Vaccine Immunol. 2001. 8:1-8. [HTML] [PDF]

New Methods for Assessing T-Cell Responses

Nadege Bercovici, Marie-Therese Duffour, Sudhanshu Agrawal, Margarita Salcedo, and Jean-Pierre Abastado
Clin. Vaccine Immunol. 2000. 7:859-864. [HTML] [PDF]

Detection and Function of Opioid Receptors on Cells from the Immune System

Jean M. Bidlack
Clin. Vaccine Immunol. 2000. 7:719-723. [HTML] [PDF]

Clinical Manifestations of Tick-Borne Infections in Children

Kristina A. Bryant and Gary S. Marshall
Clin. Vaccine Immunol. 2000. 7:523-527. [HTML] [PDF]

Monitoring of Antigen-Specific Cytolytic T Lymphocytes in Cancer Patients Receiving Immunotherapy

Theresa L. Whiteside
Clin. Vaccine Immunol. 2000. 7:327-332. [HTML] [PDF]

Immunoglobulin D: Properties, Measurement, and Clinical Relevance

Adrian O. Vladutiu
Clin. Vaccine Immunol. 2000. 7:131-140. [HTML] [PDF]

Testing for and Clinical Significance of Anticardiolipin Antibodies

Stephen W. Reddel and Steven A. Krilis
Clin. Vaccine Immunol. 1999. 6:775-782. [HTML] [PDF]

Clinical Utility of Testing for Antineutrophil Cytoplasmic Antibodies

Dimitrios Vassilopoulos and Gary S. Hoffman
Clin. Vaccine Immunol. 1999. 6:645-651. [HTML] [PDF]

Proposed Mechanisms of Transfusion-Induced Immunomodulation

Scott A. Kirkley
Clin. Vaccine Immunol. 1999. 6:652-657. [HTML] [PDF]

Current Concepts in Human Immunodeficiency Virus Infection and AIDS

Stanley A. Schwartz and Madhavan P.?N. Nair
Clin. Vaccine Immunol. 1999. 6:295-305. [HTML] [PDF]

Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease

Sami T. Azar, Hala Tamim, Hayfa N. Beyhum, M. Zouhair Habbal, and Wassim Y. Almawi
Clin. Vaccine Immunol. 1999. 6:306-310. [HTML] [PDF]

Immunological Features of Pneumocystis carinii Infection in Humans

Peter D. Walzer
Clin. Vaccine Immunol. 1999. 6:149-155. [HTML] [PDF]

Anti-Endothelial Cell Antibodies in Systemic Sclerosis

Yves Renaudineau, Ronan Revelen, Yair Levy, Konstantin Salojin, Boris Gilburg, Yehuda Shoenfeld, and Pierre Youinou
Clin. Vaccine Immunol. 1999. 6:156-160. [HTML] [PDF]

Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection

John L. Fahey
Clin. Vaccine Immunol. 1998. 5:597-603. [HTML] [PDF]

Detection of Human Immunodeficiency Virus Antibodies in Oral Fluids

R. L. Hodinka, T. Nagashunmugam, and D. Malamud
Clin. Vaccine Immunol. 1998. 5:419-426. [HTML] [PDF]

Immunophenotyping of Bronchoalveolar Lavage Lymphocytes

Ronald J. Harbeck
Clin. Vaccine Immunol. 1998. 5:271-277. [HTML] [PDF]

Poliomyelitis: Present Epidemiological Situation and Vaccination Problems

Carolina Mensi and Fabrizio Pregliasco
Clin. Vaccine Immunol. 1998. 5:278-280. [HTML] [PDF]

Antibody Responses to DNA in Normal Immunity and Aberrant Immunity

David S. Pisetsky
Clin. Vaccine Immunol. 1998. 5:1-6. [HTML] [PDF]

Clinical, bacteriological, and serological aspects of Klebsiella infections and their spondylarthropathic sequelae

H Sahly and R Podschun
Clin. Vaccine Immunol. 1997. 4:393-399. [PDF]

Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases

PP Sfikakis and GC Tsokos
Clin. Vaccine Immunol. 1997. 4:241-246. [PDF]

Advances in dengue diagnosis

MG Guzman and G Kouri
Clin. Vaccine Immunol. 1996. 3:621-627. [PDF]

Immunodiagnosis of viral hepatitides A to E and non-A to -E

G Yang and GN Vyas
Clin. Vaccine Immunol. 1996. 3:247-256. [PDF]

Laboratory tests for detection of human immunodeficiency virus type 1 infection

NF Nuwayhid
Clin. Vaccine Immunol. 1995. 2:637-645. [PDF]

Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals

A Gorski and JW Kupiec-Weglinski
Clin. Vaccine Immunol. 1995. 2:646-651. [PDF]

Clinical utility of complement assessment

AE Ahmed and JB Peter
Clin. Vaccine Immunol. 1995. 2:509-517. [PDF]

X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis

NL Farner, SD Voss, and PM Sondel
Clin. Vaccine Immunol. 1995. 2:518-523. [PDF]

Structural and functional properties of human lambda-light-chain variable-region subgroups

A Solomon and DT Weiss
Clin. Vaccine Immunol. 1995. 2:387-394. [PDF]

The molecular genetics of hematologic malignancies

A Bagg
Clin. Vaccine Immunol. 1995. 2:255-262. [PDF]

Laboratory evaluation of the inflammatory myopathies

LG Rider and FW Miller
Clin. Vaccine Immunol. 1995. 2:1-9. [Abstract] [PDF]

Human Immunoglobulins for intravenous use and hepatitis C viral transmission

HB Slade
Clin. Vaccine Immunol. 1994. 1:613-619. [PDF]

Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

K Kuus-Reichel, LS Grauer, LM Karavodin, C Knott, M Krusemeier, and NE Kay
Clin. Vaccine Immunol. 1994. 1:365-372. [Abstract] [PDF]

Cytokines and cytokine measurements in a clinical laboratory

TL Whiteside
Clin. Vaccine Immunol. 1994. 1:257-260. [PDF]

Role of human natural killer cells in health and disease

TL Whiteside and RB Herberman
Clin. Vaccine Immunol. 1994. 1:125-133. [Abstract] [PDF]

Vaccine immune response and side effects with the use of acetaminophen with influenza vaccine

PA Gross, RA Levandowski, C Russo, M Weksler, J Bonelli, S Dran, G Munk, S Deichmiller, R Hilsen, and RF Panush
Clin. Vaccine Immunol. 1994. 1:134-138. [Abstract] [PDF]

Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children

RD Semba, Muhilal, AL Scott, G Natadisastra, KP West Jr, and A Sommer
Clin. Vaccine Immunol. 1994. 1:172-175. [Abstract] [PDF]

Adhesion molecules in host defense

A Etzioni
Clin. Vaccine Immunol. 1994. 1:1-4. [PDF]